Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Germany sees third consecutive diesel price record after rule change - 2Rio Tinto resumes operations at three Pilbara port terminals after cyclone Narelle
- 3‘The White Lotus’ sparked online interest in risky anxiety pills, study says
- 4Thyssenkrupp to suspend electrical steel production at French site
- 5Public Parks in the USA
- As world leaders enter climate talks, people in poverty have the most at stake
- Israeli forces kill one person in series of attacks on southern Lebanon
- Flu is rising rapidly, driven by a new variant. Here's what to know
- Figure out How to Augment Eco-friendliness in Your Volvo XC40
- Spots To Go Birdwatching All over the Planet
- Plane Passenger Allegedly Includes ‘Bomb Threat’ in Hotspot Network Name, Forces Flight to Make Emergency Landing
- High Court weighs Assenheim appeal over release of Feldstein interview raw footage
- Find the Future of Outsourcing: Exploring the Gig Economy
- Barry Manilow reveals lung cancer diagnosis and plans to undergo surgery: 'It's pure luck' it was 'found so early'
